
220.25 Delayed Data As of May 26 | ![]() Today’s Change | 93.47 Today|||52-Week Range 278.25 | +12.09% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $8.2B |
Karuna Therapeutics, Inc. 99 High Street Boston Massachusetts 02110 |
William J. Meury | President, Chief Executive Officer & Director |
Andrew Miller | Chief Operating Officer |
Troy A. Ignelzi | Chief Financial Officer |
Stephen Brannan | Chief Medical Officer |
Steven Marc Paul | Director, Chief Scientific Officer, President-R&D |